CEO and senior executives in Egetis Therapeutics acquire shares
July 12, 2021
Egetis Therapeutics AB (publ) (ticker: EGTX) today announced that Nicklas Westerholm, CEO, Kristina Sjöblom Nygren, CMO, and Henrik Krook, Vice President Commercial Operations, have acquired shares in the company.
Nicklas Westerholm has bought 11,000 additional shares, Kristina Sjöblom Nygren has bought 2,000 shares and Henrik Krook has bought 35,000 additional shares. Their respective total holdings now amount to 48,715, 2,000 and 108,955 shares in addition to warrants and employee stock options.